ATP8B1 and prostate carcinoma: The investigated association of 222 haplotype-tagging SNPs in eight phospholipid-transporting ATPase genes with cancer-specific survival and overall survival of 630 patients treated with androgen-deprivation therapy (ADT) for prostate cancer revealed that ATP8B1 was under-expressed in tumor tissues, and that a higher ATP8B1 expression was associated with a better patient prognosis [49].